Vicapsys Life Sciences Inc
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and … Read more
Market Cap & Net Worth: Vicapsys Life Sciences Inc (VICP)
Vicapsys Life Sciences Inc (PINK:VICP) has a market capitalization of $57.30 Million ($57.30 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #23230 globally and #8142 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vicapsys Life Sciences Inc's stock price $1.77 by its total outstanding shares 32371299 (32.37 Million).
Vicapsys Life Sciences Inc Market Cap History: 2015 to 2025
Vicapsys Life Sciences Inc's market capitalization history from 2015 to 2025. Data shows growth from $5.18 Million to $57.30 Million (29.26% CAGR).
Vicapsys Life Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vicapsys Life Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
119.88x
Vicapsys Life Sciences Inc's market cap is 119.88 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $89.02 Million | $742.59K | -$2.20 Million | 119.88x | N/A |
Competitor Companies of VICP by Market Capitalization
Companies near Vicapsys Life Sciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Vicapsys Life Sciences Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Vicapsys Life Sciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Vicapsys Life Sciences Inc's market cap moved from $5.18 Million to $ 57.30 Million, with a yearly change of 29.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $57.30 Million | -74.71% |
| 2024 | $226.60 Million | +155.47% |
| 2023 | $88.70 Million | +174.00% |
| 2022 | $32.37 Million | -50.00% |
| 2021 | $64.74 Million | +33.33% |
| 2020 | $48.56 Million | 0.00% |
| 2019 | $48.56 Million | -45.45% |
| 2018 | $89.02 Million | -23.61% |
| 2017 | $116.54 Million | -10.00% |
| 2016 | $129.49 Million | +2400.00% |
| 2015 | $5.18 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vicapsys Life Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $57.30 Million USD |
| MoneyControl | $57.30 Million USD |
| MarketWatch | $57.30 Million USD |
| marketcap.company | $57.30 Million USD |
| Reuters | $57.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.